AB&B BIO-TECH-B

2627
29.3200.00% ( 0.000 )
Delay Suspended: Nov 17, 09:29:26

Profile

About

AB&B BIO-TECH-B
AB&B BIO-TECH-B
02627.HK

Ab&B Bio-Tech CO., LTD. JS engages in the research, development, manufacturing, and commercialization of vaccines in China. The company offers quadrivalent subunit influenza and trivalent subunit influenza vaccines. Its product pipeline also includes lyophilized human rabies, pneumococcal polysaccharide vaccine 23, and recombinant zoster vaccine which is in phase I clinical trial; and adjuvanted quadrivalent subunit influenza, adjuvanted trivalent subunit influenza, recombinant RSV, mRNA mpox, mRNA respiratory syncytial virus (RSV), pneumococcal conjugate vaccine 24, live attenuated varicella, and tetanus toxoid adsorbed vaccines which is in preclinical trial.

Profile

Company Name
Ab&B Bio-Tech CO., LTD. JS
Market
SEHK
Founded
Industry
--
Fiscal Year End
--

Related Securities

Industry

Management